Sheffield, United Kingdom
SleepCogni is a British award-winning first-in-class medical device for the diagnosis and treatment of sleep disorders. SleepCogni’s patented bedside and wearable device system helps sleep professionals better understand insomniacs and offers a range of proven interventions, such as CBT-I. The company offers a comprehensive digital and technological solution integrating information on physiology, behavior, and the sleeping environment.
Founded in 2015, SleepCogni is headquartered in the United Kingdom. The company is funded by one of the UK's leading venture capital funds, Mercia Technologies Plc, and more recently by the UK’s governmental Innovation agency, InnovateUK. The last investment of £340.00K as a grant was received on 25 April 2024, from Innovate UK.
The company is working with some of the world's leading technologists, sleep clinicians, and universities. Currently, SleepCogni is moving from the research & development phase towards clinically validating the device’s measurements, before moving onto clinical trials in 2018.
SleepCogni’s team is passionate and dedicated to making a global difference by solving the surprisingly common problem that many (1 in 3) people face: trouble sleeping. Their focus on integrating technology and medical expertise shows promise for addressing this widespread issue.
